Metabolic and Addiction Indices in Patients on Opioid Agonist Medication-Assisted Treatment: A Comparison of Buprenorphine and Methadone

Keyphrases

• Addiction 100%
• Metabolic 100%
• Methadone 100%
• Opioid Agonist Treatment 100%
• Buprenorphine 100%
• Medication-assisted Treatment 100%
• High-density Lipoprotein Cholesterol (HDL-C) 57%
• Hemoglobin A1c (HbA1c) 28%
• Exposure Time 28%
• Metabolic Syndrome 28%
• Oral Glucose Tolerance Test 28%
• Sweet Taste Test 28%
• Metabolic Effects 14%
• Test Performance 14%
• Correspondence Analysis 14%
• Low Dose Rate 14%
• Triglycerides 14%
• Blood Pressure 14%
• Metabolic Function 14%
• Distinctive Features 14%
• Fasting Plasma Glucose 14%
• Insulin Resistance 14%
• Plasma Lipids 14%
• Overweight or Obesity 14%
• Obese Resistant 14%
• Metabolic Processes 14%
• Body Composition 14%
• Metabolic Derangements 14%
• Reward Circuit 14%
• Data Call 14%
• Addiction Severity Index 14%
• Opioid Use Disorder 14%
• Brain Stimulation Reward 14%
• Metabolic Hormones 14%
• Opioid Consumption 14%
• Agonist Drugs 14%
• Medications for Opioid Use Disorder 14%
• Opioid Craving 14%
• Motivational Circuits 14%

Neuroscience

• Agonist 100%
• Methadone 100%
• Buprenorphine 100%
• High-Density Lipoprotein 57%
• Sensation of Taste 28%
• Glucose Tolerance Test 28%
• Triacylglycerol 14%
• Blood Plasma 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Opiate Agonist 100%
• Methadone 100%
• Buprenorphine 100%
• High Density Lipoprotein 57%
• Metabolic Syndrome X 28%
• Diseases 28%
• Triacylglycerol 14%